Risk factor
Very poor trading liquidity
Profitability factor
Strong growth
About
Stille AB develops, manufactures, and distributes medtech products in Sweden and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascular, and anastomosis clamps; skin and nerve hooks, retractors, rib spreaders, self-retaining and trachea retractors, and nasal specula; and dressing, diathermy, knot-holding, tissue, iris, dura, and vascular forceps under the STILLE, Fehling, and S&T brands. Its Surgical Tables segment provides C-arm tables, which are surgical tables used in ERCP/abdominal fluoroscopy, neuro/spine, pain management, urology, and vascular procedures under the imagiQ and MedStone brands. The company also offers instrument care education, repair and maintenance, and inspection services. Stille AB was founded in 1841 and is headquartered in Torshälla, Sweden.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, o
Target Price
The average target price of STIL.ST is 282 and suggests 22.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in